
Insiders Updates
Understanding the Risks of Investing in Plus Therapeutics Inc (PSTV)
Plus Therapeutics Inc’s recent filing unveils that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug
Plus Therapeutics Inc’s recent filing unveils that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug
In a filing, Plus Therapeutics Inc revealed its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug
Plus Therapeutics Inc’s filing revealed that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug 22
Plus Therapeutics Inc’s recent filing unveils that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug
Plus Therapeutics, Inc. (PTSV) stock prices were up an impressive 16.5% as of market close on April 21st, 2021, bringing